Canada markets closed

Esperion Therapeutics, Inc. (ESPR)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
2.43000.0000 (0.00%)
At close: 04:00PM EDT
2.4300 0.00 (0.00%)
After hours: 07:54PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 459.44M
Enterprise Value 501.82M
Trailing P/E N/A
Forward P/E 10.55
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.38
Price/Book (mrq)98.42
Enterprise Value/Revenue 2.18
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.02
52-Week Change 354.78%
S&P500 52-Week Change 318.96%
52 Week High 33.4000
52 Week Low 30.7000
50-Day Moving Average 32.4348
200-Day Moving Average 32.0942

Share Statistics

Avg Vol (3 month) 38.32M
Avg Vol (10 day) 35.05M
Shares Outstanding 5189.46M
Implied Shares Outstanding 6189.46M
Float 8164.17M
% Held by Insiders 10.52%
% Held by Institutions 169.18%
Shares Short (Jul 15, 2024) 439.42M
Short Ratio (Jul 15, 2024) 43.93
Short % of Float (Jul 15, 2024) 420.86%
Short % of Shares Outstanding (Jul 15, 2024) 420.80%
Shares Short (prior month Jun 14, 2024) 424.89M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin -37.65%
Operating Margin (ttm)52.47%

Management Effectiveness

Return on Assets (ttm)-6.94%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)229.74M
Revenue Per Share (ttm)1.83
Quarterly Revenue Growth (yoy)466.10%
Gross Profit (ttm)N/A
EBITDA -34.56M
Net Income Avi to Common (ttm)-86.51M
Diluted EPS (ttm)-0.9000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)226.61M
Total Cash Per Share (mrq)1.2
Total Debt (mrq)548.87M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.22
Book Value Per Share (mrq)-1.57

Cash Flow Statement

Operating Cash Flow (ttm)-27.3M
Levered Free Cash Flow (ttm)-45.36M